Abiopharma

🔍 Benjamin Richard J (Executive)

Company: CERUS CORP (CERS)

Report Date: 2026-03-05

Detailed Transactions and Holdings:

• Acquired 55,220 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: A | equity_swap_involved: false | shares_owned_after: 1,004,995.00 | transaction_form_type: 4
• Sold 61,233 shares of Common Stock at $2.0627 per share (Direct)
  Date: 2026-03-05 | Code: S | equity_swap_involved: false | shares_owned_after: 943,762.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 24,235 shares of Common Stock at $2.0055 per share (Direct)
  Date: 2026-03-06 | Code: S | equity_swap_involved: false | shares_owned_after: 919,527.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 40,426 shares of Common Stock at $1.8807 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: false | shares_owned_after: 879,101.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
• F2: Represents a weighted average sales price. These shares were sold in a block trade per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold pursuant to such block trade.
• F3: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.855 to $1.91 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
• F4: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.17 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.